 |
4-methylpiperazine-1-carboxylic acid [1-(3-benzenesufonyl-1-phenethylallyl-carbamoyl)-2-phenylethyl] amide |
|---|---|
| Trade Name | |
| Orphan Indication | Chagas disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-11 00:00:00 |
| Sponsor | Center for Discovery & Innovation in Parasitic Diseases;University of CA, San Francisco, 9500 Gilman Drive;LaJolla, California, 92093 |
